The C868T single nucleotide polymorphism in the CD4 receptor encodes an amino acid substitution of tryptophan for arginine in the third domain. Previous studies suggest that C868T increases the risk of HIV-1 acquisition; however, the influence of this single nucleotide polymorphism (SNP) on disease progression has not been established. The presence of the C868T polymorphism was not statistically significantly associated with HIV-1 disease progression outcomes in a cohort of postpartum Kenyan women.
Get full access to this article
View all access options for this article.
References
1.
SamsonM, LibertF, DoranzBJet al.Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature, 1996; 382:722–725.
2.
HuangY, PaxtonWA, WolinskySMet al.The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med, 1996; 2:1240–1243.
3.
CohenOJ, PaolucciS, BendeSMet al.CXCR4 and CCR5 genetic polymorphisms in long-term nonprogressive human immunodeficiency virus infection: Lack of association with mutations other than CCR5-Delta32. J Virol, 1998; 72:6215–6217.
4.
PasiKJ, SabinCA, JenkinsPV, DevereuxHL, OnonyeC, LeeCA. The effects of the 32-bp CCR-5 deletion on HIV transmission and HIV disease progression in individuals with haemophilia. Br J Haematol, 2000; 111:136–142.
5.
DorrP, WestbyM, DobbsSet al.Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity. Antimicrob Agents Chemother, 2005; 49:4721–4732.
6.
McNeilAJ, YapPL, GoreSMet al.Association of HLA types A1-B8-DR3 and B27 with rapid and slow progression of HIV disease. QJM, 1996; 89:177–185.
7.
GoulderPJ, PhillipsRE, ColbertRAet al.Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med, 1997; 3:212–217.
8.
MiguelesSA, SabbaghianMS, ShupertWLet al.HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci USA, 2000; 97:2709–2714.
9.
LedermanS, DeMartinoJA, DaughertyBLet al.A single amino acid substitution in a common African allele of the CD4 molecule ablates binding of the monoclonal antibody, OKT4. Mol Immunol, 1991; 28:1171–1181.
10.
ChoiRY, FarquharC, JunoJet al.Infant CD4 C868T polymorphism is associated with increased human immunodeficiency virus (HIV-1) acquisition. Clin Exp Immunol, 2010; 160:461–465.
11.
OyugiJO, VouriotFC, AlimontiJet al.A Common CD4 gene variant is associated with an increased risk of HIV-1 infection in Kenyan female commercial sex workers. J Infect Dis, 2009; 199:1327–1334.
12.
ThaineuaV, SirinirundP, TanbanjongA, LallemantM, SoucatA, LamborayJL. From research to practice: Use of short course zidovudine to prevent mother-to-child HIV transmission in the context of routine health care in Northern Thailand. Southeast Asian J Trop Med Public Health, 1998; 29:429–442.
13.
DeVange PanteleeffD, EmeryS, RichardsonBAet al.Validation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay with genital swabs and breast milk samples. J Clin Microbiol, 2002; 40:3929–3937.
14.
EmeryS, BodrugS, RichardsonBAet al.Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya. J Clin Microbiol, 2000; 38:2688–2695.
15.
GoulderPJ, BranderC, TangYet al.Evolution and transmission of stable CTL escape mutations in HIV infection. Nature, 2001; 412:334–338.
16.
SchneidewindA, TangY, BrockmanMAet al.Maternal transmission of human immunodeficiency virus escape mutations subverts HLA-B57 immunodominance but facilitates viral control in the haploidentical infant. J Virol, 2009; 83:8616–8627.
17.
GillespieGM, KaulR, DongTet al.Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57. AIDS, 2002; 16:961–972.
18.
McKinnonLR, CapinaR, PetersHet al.Clade-specific evolution mediated by HLA-B*57/5801 in human immunodeficiency virus type 1 clade A1 p24. J Virol, 2009; 83:12636–12642.
